Cite

HARVARD Citation

    Takase, T. et al. (2020). Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban. Journal of clinical pharmacy and therapeutics. pp. 298-302. [Online]. 
  
Back to record